Literature DB >> 15557002

Synthesis of galmic: a nonpeptide galanin receptor agonist.

Susana Conde Ceide1, Laurent Trembleau, Gebhard Haberhauer, Laszlo Somogyi, Xiaoying Lu, Tamas Bartfai, Julius Rebek.   

Abstract

Galanin is a neuropeptide with a wide variety of biological functions. Few nonpeptide ligands, capable of activating galanin receptors, are available today. Based on known pharmacophores of galanin and the tripeptidomimetic galnon, a combinatorial library was formulated, synthesized, and screened against the galanin receptor. An active compound, galmic, was identified and tested in vitro and in vivo for its affinity and efficacy at galanin receptors. The present work describes the total synthesis of galmic, the synthesis of its oxazole precursors, the coupling of the building blocks into a linear trimer, and the macrolactamization reaction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557002      PMCID: PMC534730          DOI: 10.1073/pnas.0407543101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

Review 1.  Pharmacological evidence supporting a role for galanin in cognition and affect.

Authors:  C C Wrenn; J N Crawley
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-01       Impact factor: 5.067

Review 2.  The role of galanin in feeding behavior.

Authors:  J N Crawley
Journal:  Neuropeptides       Date:  1999-10       Impact factor: 3.286

Review 3.  Galanin and spinal nociceptive mechanisms: recent advances and therapeutic implications.

Authors:  X J Xu; T Hökfelt; T Bartfai; Z Wiesenfeld-Hallin
Journal:  Neuropeptides       Date:  2000 Jun-Aug       Impact factor: 3.286

4.  Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests.

Authors:  Tamas Bartfai; Xiaoying Lu; Hedieh Badie-Mahdavi; Alasdair M Barr; Andrey Mazarati; Xiao-Ying Hua; Tony Yaksh; Gebhard Haberhauer; Susana Conde Ceide; Laurent Trembleau; Laszlo Somogyi; Lenz Kröck; Julius Rebek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

Review 5.  Galanin receptor subtypes and ligand binding.

Authors:  A Florén; T Land; U Langel
Journal:  Neuropeptides       Date:  2000-12       Impact factor: 3.286

Review 6.  Neurohormonal regulation of the insulin stimulus-secretion coupling in pancreatic islets.

Authors:  A Sjöholm; S Efendić
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

7.  Galanin - a novel biologically active peptide from porcine intestine.

Authors:  K Tatemoto; A Rökaeus; H Jörnvall; T J McDonald; V Mutt
Journal:  FEBS Lett       Date:  1983-11-28       Impact factor: 4.124

8.  2,3-Dihydro-dithiin and -dithiepine-1,1,4,4-tetroxides: small molecule non-peptide antagonists of the human galanin hGAL-1 receptor.

Authors:  M K Scott; T M Ross; D H Lee; H Y Wang; R P Shank; K D Wild; C B Davis; J J Crooke; A C Potocki; A B Reitz
Journal:  Bioorg Med Chem       Date:  2000-06       Impact factor: 3.641

9.  Anticonvulsant activity of a nonpeptide galanin receptor agonist.

Authors:  Külliki Saar; Andrey M Mazarati; Riina Mahlapuu; Gerd Hallnemo; Ursel Soomets; Kalle Kilk; Sven Hellberg; Margus Pooga; Bo-Ragnar Tolf; Tiejun S Shi; Tomas Hökfelt; Claude Wasterlain; Tamas Bartfai; Ulo Langel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

Review 10.  Gonadal steroid-dependent GAL-IR cells within the medial preoptic nucleus (MPN) and the stimulatory effects of GAL within the MPN on sexual behaviors.

Authors:  G J Bloch; P C Butler; C B Eckersell; R H Mills
Journal:  Ann N Y Acad Sci       Date:  1998-12-21       Impact factor: 5.691

View more
  5 in total

1.  Heterocyclic alpha-helix mimetics for targeting protein-protein interactions.

Authors:  Shannon M Biros; Lionel Moisan; Enrique Mann; Alexandre Carella; Dayong Zhai; John C Reed; Julius Rebek
Journal:  Bioorg Med Chem Lett       Date:  2007-05-27       Impact factor: 2.823

Review 2.  Positive allosteric modulators to peptide GPCRs: a promising class of drugs.

Authors:  Tamas Bartfai; Ming-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2013-04-29       Impact factor: 6.150

3.  Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.

Authors:  Cameron S Metcalf; Brian D Klein; Daniel R McDougle; Liuyin Zhang; Dan Kaufmann; Grzegorz Bulaj; H Steve White
Journal:  Epilepsia       Date:  2017-01-18       Impact factor: 5.864

4.  Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

Authors:  Cameron S Metcalf; Misty D Smith; Brian D Klein; Daniel R McDougle; Liuyin Zhang; Grzegorz Bulaj
Journal:  Neurochem Res       Date:  2017-04-06       Impact factor: 3.996

5.  Galanin receptors and ligands.

Authors:  Kristin E B Webling; Johan Runesson; Tamas Bartfai; Ulo Langel
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-07       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.